Latest Safety News

Native Mineral Resources (ASX:NMR) recorded its strongest monthly processing since recommissioning in April 2026, with 24,101 dry tonnes milled and a 20% rise in gold recovered. The transition to higher-grade feed from Blackjack Mid Pit and Podosky is set to underpin production gains through FY2027.

TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.

Imugene Limited’s allogeneic CAR T therapy, azer-cel, delivered an 81% overall response rate in a Phase 1b trial cohort of CAR T-naïve patients with various CD19 B-cell malignancies, with updated data due at ASCO 2026.

Avira Resources has kicked off siteworks at its Mt Cattlin Gold Project ahead of a 4,500-metre RC drilling program targeting a maiden resource estimate by year-end.

GR Engineering Services has locked in a $229 million EPC contract with Genesis Minerals to deliver the Tower Hill Gold Project, cementing its role in a 3.5-4.0Mtpa gold operation near Leonora.

ClearVue Technologies has secured a A$305,000 contract to supply over 800m² of building-integrated photovoltaic glazing for the Rio Business Centre redevelopment in Paphos, Cyprus, marking a tangible commercial step for its solar façade technology.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.

SGH Ltd’s Investor Day showcased its diversified portfolio strength, with key insights into operational performance and strategic priorities across WesTrac, Boral, Coates, and its significant energy and media holdings.

Ventia Services Group reported a strong FY25 with revenue of $6.1 billion and 13% NPATA growth, while CEO Dean Banks announced his planned departure later this year. The company reaffirmed its FY26 guidance and highlighted growth opportunities in Defence, Digital Infrastructure, Energy, and Water.

MyEco Group has extended its partnership with Penrith City Council by winning a 3-to-5-year contract to supply compostable caddy liners for the council's FOGO program, aligning with NSW's mandated organics recycling rollout.

Patrys has appointed CMAX and Alithia Life Sciences to lead its Phase 1A clinical trial operations for RLS-2202, advancing its injectable quetiapine program toward first-in-human testing in Q3 2026, pending ethics approval.

Hydrix Limited has bolstered its balance sheet by raising $3.89 million and converting $5.1 million of debt into equity, positioning itself to expand its Defence technology footprint following a $1.2 million contract with NIOA Group.